| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BIBW2992 | FIMM | pan-cancer | AAC | -0.031 | 0.8 |
| mRNA | CP466722 | GDSC1000 | pan-cancer | AAC | 0.0062 | 0.8 |
| mRNA | COL-3 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.9 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.014 | 0.9 |
| mRNA | tivantinib | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.9 |
| mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.9 |
| mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | 0.0069 | 0.9 |